Zutphen, The Netherlands - 10 March 2017

Esperite N.V. (Euronext: ESP, "Esperite") announces that it has convened an Extraordinary General Meeting of Shareholders ("EGM") to be held on Friday 21 April 2017 at 14:00 hours CET at Hotel NH Amsterdam Barbizon Palace, Prins Hendrikkade, 59-72, 1012 AD, Amsterdam, The Netherlands.

At the EGM, Esperite's Board of Directors will inter alia present to its shareholders the details of the recently announced external financing of up to EUR 13 million and propose to approve the issuance of further tranches of convertible notes (with share subscription warrants attached) to European Select Growth Opportunities Fund.

The EGM's convocation notice, agenda and the explanatory notes to the agenda and further EGM materials can be downloaded from Esperite's website (www.esperite.com) and are available free of charge at Esperite's offices in Zutphen, The Netherlands. Shareholders interested in attending the EGM are invited to contact Esperite: +31 575 548 998 and ir@esperite.com.

About ESPERITE N.V.
ESPERITE Group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and precision medicine founded in 2000.

ESPERITE PR EGM


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Esperite N.V. via Globenewswire